Who We Are
- Leadership
- Partnership
Our Science
Pipeline & Products
- Products
- Clinical Trials
Newsroom
- Events & Posters
- Press Releases
Careers
- Our Culture
Contact Us

Pulmonary and motor function in ambulatory and nonambulatory participants with Duchenne muscular dystrophy treated with viltolarsen

Back to Press Releases

Who We Are
Our Science
Pipeline & Products
Newsroom
Careers
Contact Us

View our Privacy Notice, Terms of
Use and Corporate Compliance.

Do Not Sell or Share My Personal Information

Consumer Health Data Privacy Notice

© 2026 NS Pharma, Inc. All rights reserved.

NS Pharma, the NS Pharma symbol and Viltepso® are registered trademarks of Nippon Shinyaku Co., Ltd.
We Speak Duchenne, We Speak Duchenne logo and the NS Support logo are registered trademarks of NS Pharma, Inc.

US-NSPCO-0107